Vertebral osteomyelitis in patients with infective endocarditis: prevalence, risk factors and mortality
- PMID: 39836291
- PMCID: PMC11947019
- DOI: 10.1007/s10096-025-05041-8
Vertebral osteomyelitis in patients with infective endocarditis: prevalence, risk factors and mortality
Abstract
Purpose: Infective endocarditis (IE) can be complicated by vertebral osteomyelitis (VO). This study investigates risk factors associated with VO in patients with infective endocarditis, and 6-month mortality and relapse rates in patients with IE and concomitant VO.
Methods: We performed a observational study in two hospitals between September 2016 and October 2022. Patients with possible or definite IE according European Society of Cardiology (2015) modified criteria were retrieved from the local endocarditis team registries. The VO diagnosis was based on radiological signs, irrespective of clinical symptoms. Multivariable logistic regression analysis was performed to identify risk factors for vertebral osteomyelitis.
Results: We included 633 consecutive patients with IE. A total of 229 (36.2%) patients had prosthetic valves and 127 (20.1%) had cardiac implantable electronic devices. The most frequent causative micro-organism was Streptococcus species (217, 34.3%), followed by Staphylococcus aureus (167, 26.4%). VO was diagnosed in 73 patients (11.5%, 95% CI 9.0%-14.0%). Enterococcus spp.(OR 2.48, 95% CI 1.31-4.52) and age (OR 1.04 per year, 95% CI 1.02-1.06) were independently associated with concomitant VO. The 6-month mortality risk did not differ between patients with (16/73, 21.9%) or without (110/560, 19.6%) VO (HR 1.13, 95% CI 0.67-1.91). Relapse rate was higher in patients with VO but the difference was not statistically significant (16.1 vs. 7.5%, OR 3.62, 95% CI 0.94-13.34).
Conclusions: Twelve percent of patients with IE also had VO. Among older patients and patients with IE caused by enterococci, there should be a higher index of suspicion for vertebral infection.
Keywords: Age; Enterococci; Infectious endocarditis; Spondylodiscitis; Vertebral osteomyelitis.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethical approval: This study is an observational study. The study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of University of Amsterdam UMC (Date 12-10-2023./No METC2023.0424). In the Noordwest Hospital the Research Ethics Committee has confirmed that no ethical approval is required. Competing interests: Dr. van Werkhoven has received grants from DaVolterra, bioMerieux and LimmaTech which were paid to the institution. Dr. van Werkhoven has received consulting fees from Merck/MSD and Sanofi-Pasteur in regards to pneumococcal vaccines. These payments were made to the institution.
Figures
Similar articles
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
The occurrence of infective endocarditis with Staphylococcus lugdunensis bacteremia: A retrospective cohort study and systematic review.J Infect. 2017 Feb;74(2):179-186. doi: 10.1016/j.jinf.2016.10.003. Epub 2016 Oct 22. J Infect. 2017. PMID: 27777118
-
Antibiotic prophylaxis for preventing bacterial endocarditis following dental procedures.Cochrane Database Syst Rev. 2022 May 10;5(5):CD003813. doi: 10.1002/14651858.CD003813.pub5. Cochrane Database Syst Rev. 2022. PMID: 35536541 Free PMC article.
-
Vertebral osteomyelitis in patients with an underlying malignancy or chronic kidney disease - who is at higher risk for adverse outcome?Infection. 2025 Aug;53(4):1363-1372. doi: 10.1007/s15010-024-02451-2. Epub 2024 Dec 21. Infection. 2025. PMID: 39708242 Free PMC article.
-
Sertindole for schizophrenia.Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2. Cochrane Database Syst Rev. 2005. PMID: 16034864 Free PMC article.
References
-
- de Sèze S, Ryckewaert A, Kahn MF, Simonin JL, Heuleu JN (Dec 1965) [Osler’s endocarditis in rheumatology]. (in Fre), Rev Rhum Mal Osteoartic, L’endocardite d’Osler en rhumatologie 32(12):739–744. - PubMed
-
- Carbone A et al (Dec 2020) Spondylodiscitis complicating infective endocarditis, Heart 106(24):1914–1918. 10.1136/heartjnl-2019-316492 - PubMed
-
- Tamura K (2010) Clinical characteristics of infective endocarditis with vertebral osteomyelitis. J Infect Chemother 16(4):260–265. 01/01/2010 10.1007/s10156-010-0046-8 - PubMed
-
- Le Moal G et al (Sep 2002) Clinical and laboratory characteristics of infective endocarditis when associated with spondylodiscitis. Eur J Clin Microbiol Infect Dis 21(9):671–675. 10.1007/s10096-002-0798-x - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous